Described herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medicine, these programs including a syringe using an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging w